A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction

Summary

The purpose of this pilot study is to evaluate the effectiveness of the active involvement of Community Pharmacists in improving adherence to medical prescriptions in patients with acute myocardial infarction (AMI), reducing the rate of adverse events and / or re-admissions due to cardiovascular disease and reducing overall health costs. The Hospital and Community Pharmacists will collaborate with each other, the patients, heart specialists and primary care physicians, throughout 12 months from the hospital discharge.

Conditions

• Myocardial Infarction, Acute
• ST Segment Elevation Myocardial Infarction
• Non-ST Elevation Myocardial Infarction (nSTEMI)

Interventions

BEHAVIORAL

Patient-counseling

After one month from the hospital discharge, the pharmacist will give to the patient general advices and suggestions regarding disease, therapy and drugs.

BEHAVIORAL

Patient self-administered questionnaire

The pharmacist will submit the questionnaire to the patient for the evaluation of drug adherence, life style, feelings and approach to therapies, at 30 days, 3, 6, 9 and 12 months from the enrollment. This self-questionnaire of 13 questions contains the 8 multiple choice questions of the Morisky medication adherence scale (MMAS-8-Item, Italian version).

BEHAVIORAL

Pills counts

At the time of the monthly drug re-supply at the community pharmacy, the patient will bring the boxes of the drugs taken in the previous month (empty or not), for the pill counts. The pharmacist will verify the correct assumption of the pharmacological therapies.

Sponsors & Collaborators

• University of Padova

  collaborator OTHER

• Azienda ULSS 5 Polesana

  lead OTHER

Principal Investigators

• Raffaella Ruzza, University · Azienda ULSS 5 Polesana

• Erika Vighesso, University · University of Padova

• Gianni Bregola, University · Azienda ULSS 5 Polesana

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-02-19

Primary Completion

2019-02-19

Completion

2019-08-19

Countries

• Italy

Study Locations